Analysis of mass spectrometry data from the secretome of an explant model of articular cartilage exposed to pro-inflammatory and anti-inflammatory stimuli using machine learning

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Swan, Anna L ^a   Hillier, Kirsty L ^a   Smith, Julia R ^b   Allaway, David ^c   Liddell, Susan ^a   Bacardit, Jaume ^a,d   Mobasheri, Ali ^a,e,f,g  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Bruker UK Limited   (United Kingdom)

^c WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Bioinformatics; Biomarker; Carprofen; Cartilage; Interleukin 1 ; Machine learning; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER; CARPROFEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; OSTEOCALCIN; PROTEIN; PROTEOME; SECRETOME; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; BIOINFORMATICS; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPLANT; IN VITRO STUDY; MACHINE LEARNING; MASS SPECTROMETRY; NETWORK LEARNING; NONHUMAN; OSTEOARTHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS;

ANIMALS; ARTIFICIAL INTELLIGENCE; CARTILAGE, ARTICULAR; DOGS; INTERLEUKIN-1BETA; MALE; MASS SPECTROMETRY; OSTEOARTHRITIS; PROTEINS; PROTEOME;

EID: 84889971850     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-349     Document Type: Article

References (60)

1. Proteomic analysis of cartilage- and bone-associated samples. Lammi MJ, Häyrinen J, Mahonen A, ELECTROPHORESIS 2006 27 13 2687 2701 10.1002/elps.200600004 16739228 (Pubitemid 44057520)
2. Articular cartilage and changes in arthritis: collagen of articular cartilage. Eyre D, Arthritis Res 2002 4 1 30 35 10.1186/ar380 11879535 (Pubitemid 34100487)
3. Influence of decreasing nutrient path length on the development of engineered cartilage. Bian L, Angione SL, Ng KW, Lima EG, Williams DY, Mao DQ, Ateshian GA, Hung CT, Osteoarthr Cartilage 2009 17 5 677 685 10.1016/j.joca.2008.10.003
4. Articular cartilage repair. Newman AP, Am J Sports Med 1998 26 2 309 324 9548130 (Pubitemid 28157992)
5. The pathophysiology and medical management of canine osteoarthritis. Vaughan-Scott T, Taylor JH, J S Afr Vet Assoc 1997 68 1 21 25 9186936 (Pubitemid 27201876)
6. The impact of osteoarthritis: implications for research. Buckwalter JA, Saltzman C, Brown T, Clin Orthop Relat R 2004 427 6 S15 10.1097/1001.blo. 0000143938.0000130681.0000143939d
7. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Goldring MB, Best Pract Res Clin Rheumatol 2006 20 5 1003 1025 10.1016/j.berh.2006.06.003 16980220 (Pubitemid 44382386)
8. An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model. Macrory L, Vaughan-Thomas A, Clegg P, Innes J, BMC Vet Res 2009 5 1 25 10.1186/1746-6148-5-25 19624842
9. Mechanical determinants of osteoarthrosis. Radin EL, Burr DB, Caterson B, Fyhrie D, Brown TD, Boyd RD, Semin arthritis rheu 1991 21 3, Supplement 2 12 21 10.1016/0049-0172(91)90036-Y
10. Osteoarthritis. A continuing challenge. Sack KE, Western J Med 1995 163 6 579 586
11. Osteoarthritis year 2012 in review: biomarkers. Mobasheri A, Osteoarthr Cartilage 2012 20 12 1451 1464 10.1016/j.joca.2012.07.009
12. Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP biomarker workshop. Bai JP, Bell R, Buckman S, Burckart GJ, Eichler HG, Fang KC, Goodsaid FM, Jusko WJ, Lesko LL, Meibohm B, et al. AAPS J 2011 13 2 274 283 10.1208/s12248-011-9265-x 21448748
13. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, Gardiner J, Garnero P, Hardin J, Henrotin Y, et al. Osteoarthr Cartilage 2011 19 5 515 542 10.1016/j.joca.2010.08.019
14. Application of biochemical markers in development of drugs for treatment of osteoarthritis. Qvist P, Christiansen C, Karsdal MA, Madsen SH, Sondergaard BC, Bay-Jensen AC, Biomarkers 2010 15 1 1 19 10.3109/13547500903295873 20085489
15. Biochemical markers of joint tissue turnover. Bay-Jensen AC, Sondergaard BC, Christiansen C, Karsdal MA, Madsen SH, Qvist P, Assay Drug Dev Technol 2010 8 1 118 124 10.1089/adt.2009.0199 19715454
16. Classification of osteoarthritis biomarkers: a proposed approach. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, et al. Osteoarthr and Cartilage 2006 14 8 723 727 10.1016/j.joca.2006.04.001 (Pubitemid 43986366)
17. Whither osteoarthritis biomarkers? Felson DT, Lohmander LS, Osteoarthr cartilage/OARS, Osteoarthr Res Soc 2009 17 4 419 422 10.1016/j.joca.2009.02.004
18. Biomarker discovery in animal health and disease: the application of post-genomic technologies. Moore RE, Kirwan J, Doherty MK, Whitfield PD, Biomarker insights 2007 2 185 196 19662203
19. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Ruiz-Romero C, Blanco FJ, Osteoarthr Cartilage 2010 18 4 500 509 10.1016/j.joca.2009.11.012
20. Application for proteomic techniques in studying osteoarthritis: a review. Gharbi M, Deberg M, Henrotin Y, Front Physiol 2011 2 90 22144964
21. Royce PM, Steinmann B, Connective tissue and its heritable disorders: molecular, genetic, and medical aspects New York: John Wiley & Sons 2002
22. Articular cartilage: tissue design and chondrocyte-matrix interactions. Buckwalter JA, Mankin HJ, Instructional course lectures 1998 47 477 486 9571449
23. Weight bearing controls glycosaminoglycan concentration and articualr cartilage thickness in the knee joints of young beagle dogs. Kiviranta I, Jurvelin J, Tammi M, SääMäunen A-M, Helminen HJ, Arthritis & Rheumatism 1987 30 7 801 809 10.1002/art.1780300710 3619962 (Pubitemid 17145217)
24. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegård D, Hollander AP, Matrix Biol 2003 22 3 267 278 10.1016/S0945-053X(03)00034-9 12853037 (Pubitemid 36802369)
25. Gene expression in chondrocytes assessed with use of microarrays. Aigner T, Zien A, Hanisch D, Zimmer R, J Bone Joint Surg Am 2003 85-A Suppl 2 117 123 12721354 (Pubitemid 36535054)
26. Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics. Deutsch EW, Lam H, Aebersold R, Physiol Genomics 2008 33 1 18 25 10.1152/physiolgenomics.00298.2007 18212004 (Pubitemid 351451370)
27. Bioinformatics in the post-sequence era. Kanehisa M, Bork P, Nat Genet 2003 33 305 310 10.1038/ng1109 12610540 (Pubitemid 36278840)
28. Machine learning in bioinformatics. Larrañaga P, Calvo B, Santana R, Bielza C, Galdiano J, Inza I, Lozano JA, Armañanzas R, Santafé G, Pérez A, et al. Brief Bioinform 2006 7 1 86 112 10.1093/bib/bbk007 16761367 (Pubitemid 44417933)
29. Kotsiantis SB, Supervised machine learning: a review of classification techniques IOS Press: Emerging Artificial Intelligence Applications in Computer Engineering Proceedings of the 2007 conference on emerging artificial intelligence applications in computer engineering: real word AI systems with applications in eHealth, HCI, information retrieval and pervasive technologies. 2007 3 24
30. Separate-and-conquer rule learning. Fürnkranz J, Artif Intell Rev 1999 13 1 3 54 10.1023/A:1006524209794
31. Improving the scalability of rule-based evolutionary learning. Bacardit J, Burke E, Krasnogor N, Memetic Computing 2009 1 55 67 10.1007/s12293-008-0005- 4
32. Witten I, Frank E, Hall M, Data mining: practical machine learning tools and techniques San Francisco, CA: Morgan Kaufmann 3 2011
33. High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation. Clutterbuck AL, Smith JR, Allaway D, Harris P, Liddell S, Mobasheri A, J Proteomics 2011 74 5 704 715 10.1016/j.jprot.2011. 02.017 21354348
34. A novel technique to specifically analyze the secretome of cells and tissues. Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, Schulte-Hermann R, Gerner C, ELECTROPHORESIS 2005 26 14 2779 2785 10.1002/elps.200410387 15966010 (Pubitemid 41078987)
35. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M, Mol Cell Proteomics 2005 4 9 1265 1272 10.1074/mcp.M500061-MCP200 15958392 (Pubitemid 41448714)
36. Large-scale proteomic analysis of the human spliceosome. Rappsilber J, Ryder U, Lamond A, Mann M, Genome Res 2002 12 1231 1245 10.1101/gr.473902 12176931 (Pubitemid 41264425)
37. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, Anal Chem 2002 74 20 5383 5392 10.1021/ac025747h 12403597 (Pubitemid 35215372)
38. A statistical model for identifying proteins by tandem mass spectrometry. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, Anal Chem 2003 75 17 4646 4658 10.1021/ac0341261 14632076 (Pubitemid 37082259)
39. A guided tour of the trans-proteomic pipeline. Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, Tasman N, Sun Z, Nilsson E, Pratt B, Prazen B, et al. Proteomics 2010 10 6 1150 1159 10.1002/pmic.200900375 20101611
40. Kohavi R, A study of cross-validation and bootstrap for accuracy estimation and model selection 14th International joint conference on artificial intelligence: 1995. 1995 1137 1145
41. An analysis pipeline with statistical and visualization-guided knowledge discovery for Michigan-style learning classifier systems. Urbanowicz RJ, Granizo-Mackenzie A, Moore JH, Computational Intelligence Magazine, IEEE 2012 7 4 35 45
42. Functional network construction in arabidopsis using rule-based machine learning on large-scale data sets. Bassel GW, Glaab E, Marquez J, Holdsworth MJ, Bacardit J, The Plant Cell Online 2011 23 9 3101 3116 10.1105/tpc.111.088153
43. Using rule-based machine learning for candidate disease gene prioritization and sample classification of cancer gene expression data. Glaab E, Bacardit J, Garibaldi JM, Krasnogor N, PLoS ONE 2012 7 7 39932 10.1371/journal.pone.0039932 22808075
44. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 11 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
45. Recent advances in biomarkers in osteoarthritis. Patra D, Sandell LJ, Curr Opin Rheumatol 2011 23 5 465 470 10.1097/BOR.0b013e328349a32b 21720244
46. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Straubinger RK, Straubinger AF, Härter L, Jacobson RH, Chang YF, Summers BA, Erb HN, Appel MJ, Infect Immun 1997 65 4 1273 1285 9119462 (Pubitemid 27146613)
47. Matrix metalloproteinases as modulators of inflammation and innate immunity. Parks WC, Wilson CL, Lopez-Boado YS, Nat Rev Immunol 2004 4 8 617 629 10.1038/nri1418 15286728 (Pubitemid 39025047)
48. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. Okada Y, Konomi H, Yada T, Kimata K, Nagase H, FEBS Lett 1989 244 2 473 476 10.1016/0014-5793(89)80586-1 2920840 (Pubitemid 19067171)
49. Structure and expression of dog apolipoprotein A-I, E, and C-I mRNAs: implications for the evolution and functional constraints of apolipoprotein structure. Luo CC, Li WH, Chan L, J Lipid Res 1989 30 11 1735 1746 2515239 (Pubitemid 20024852)
50. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. Mahley RW, Ji Z-S, J Lipid Res 1999 40 1 1 16 9869645 (Pubitemid 29022581)
51. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. Zebboudj AF, Imura M, Boström K, J Biol Chem 2002 277 6 4388 4394 10.1074/jbc.M109683200 11741887 (Pubitemid 34968705)
52. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Dhore CR, Cleutjens JPM, Lutgens E, Cleutjens KBJM, Geusens PPM, Kitslaar PJEHM, Tordoir JHM, Spronk HMH, Vermeer C, Daemen MJAP, Arterioscler Thromb Vasc Biol 2001 21 12 1998 2003 10.1161/hq1201.100229 11742876 (Pubitemid 34219753)
53. Proteoglycans: many forms and many functions. Hardingham TE, Fosang AJ, FASEB J 1992 6 3 861 870 1740236
54. Targeting matrix metalloproteinases in inflammatory conditions. Clutterbuck AL, Asplin KE, Harris P, Allaway D, Mobasheri A, Curr Drug Targets 2009 10 12 1245 1254 10.2174/138945009789753264 19909233
55. Update on biomarkers in psoriatic arthritis. Chandran V, Gladman DD, Curr Rheumatol Rep 2010 12 4 288 294 10.1007/s11926-010-0107-0 20437120
56. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K, J Rheumatol 1999 26 2 251 258 9972954 (Pubitemid 29066724)
57. Inflammatory mediators: tracing links between obesity and osteoarthritis. Rai MF, Sandell LJ, Crit Rev Eukaryot Gene Expr 2011 21 2 131 142 10.1615/CritRevEukarGeneExpr.v21.i2.30 22077152
58. IL-8/NAP-1 is the major T-cell chemoattractant in synovial tissues of rheumatoid arthritis. Nishiura H, Tanaka J, Takeya M, Tsukano M, Kambara T, Imamura T, Clin Immunol Immunopathol 1996 80 2 179 184 10.1006/clin.1996.0112 8764563 (Pubitemid 26246985)
59. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Goldring MB, Connect Tissue Res 1999 40 1 1 11 10.3109/03008209909005273 10770646 (Pubitemid 29139343)
60. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Righetti PG, Castagna A, Antonioli P, Boschetti E, Electrophoresis 2005 26 2 297 319 10.1002/elps.200406189 15657944 (Pubitemid 40253785)